Clinical Trial Update: Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating pembrolizumab in combination with decitabine and hypofractionated radiation in pediatric and young adult patients with solid tumors o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• Dacogen (decitabine)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Childhood Solid Tumor, Childhood Lymphoma | EARLY_Phase 1 | Status: COMPLETED